People · Operator
Named in public records as an officer, director or promoter · active 2013–2015 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Solid GT, LLC | — | Biotechnology | Series C | $42.5M | $1.7B | 2015 |
| Solid Ventures, LLC | — | Pharmaceuticals | Series B | $17.0M | $578.1M | 2013 |
Gilad Hayeem at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gilad Hayeem on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andrey Zarur | 2 | 6 |
| Ilan Ganot | 2 | 3 |
| Matthew Arnold | 1 | 4 |
| Andrea Ponti | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.